TABLE 5.

RR for MAARI and Asthma Visits 0 to 14 Days After LAIV-T in Children Who Were 18 Months to 18 Years of Age

OutcomeRR 0–14 D/Prevaccination Period (95% CI)
Year 1 (1998–1999)Year 2 (1999–2000)Year 3 (2000–2001)Year 4 (2001–2002)
MAARI0.85 (0.68–1.07)0.91 (0.76–1.10)0.73 (0.59–0.90)0.80 (0.61–1.05)
Otitis media/sinusitis0.76 (0.51–1.14)0.62 (0.43–0.90)0.57 (0.39–0.84)0.78 (0.50–1.23)
URTI0.92 (0.70–1.21)1.04 (0.84–1.30)0.77 (0.6–0.98)0.83 (0.58–1.19)
LRTI0.50 (0.19–1.35)0.42 (0.19–0.96)0.73 (0.39–1.35)0.25 (0.08–0.76)
Asthma0.49 (0.19–1.30)1.25 (0.69–2.27)0.48 (0.22–1.07)1.31 (0.64–2.67)
  • Boldface indicates a significant decrease in health care utilization; URTI, upper respiratory tract illness; LRTI, lower respiratory tract illness.